Let’s see whether the hints in the CFO announcement on 20/3/2020, about record cash levels and the 3 sectors generics, speciality and contract services being in demand in the time of the coronavirus shutdowns, was true or just bullsh!t to stem the share price dive to 20 cents.
Either way, let hope for a new and improved C suite and the FDA approvals in the September and April; and the continued growth of contract services in North Carolina.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)